OncoCyte Short Term Debt vs Property Plant And Equipment Net Analysis

OCX Stock  USD 2.44  0.09  3.56%   
OncoCyte Corp financial indicator trend analysis is much more than just breaking down OncoCyte Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OncoCyte Corp is a good investment. Please check the relationship between OncoCyte Corp Short Term Debt and its Property Plant And Equipment Net accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.

Short Term Debt vs Property Plant And Equipment Net

Short Term Debt vs Property Plant And Equipment Net Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OncoCyte Corp Short Term Debt account and Property Plant And Equipment Net. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between OncoCyte Corp's Short Term Debt and Property Plant And Equipment Net is -0.09. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Property Plant And Equipment Net in the same time period over historical financial statements of OncoCyte Corp, assuming nothing else is changed. The correlation between historical values of OncoCyte Corp's Short Term Debt and Property Plant And Equipment Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of OncoCyte Corp are associated (or correlated) with its Property Plant And Equipment Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Net has no effect on the direction of Short Term Debt i.e., OncoCyte Corp's Short Term Debt and Property Plant And Equipment Net go up and down completely randomly.

Correlation Coefficient

-0.09
Relationship DirectionNegative 
Relationship StrengthInsignificant

Short Term Debt

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from OncoCyte Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OncoCyte Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.At this time, OncoCyte Corp's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 117.1 K in 2024, whereas Discontinued Operations is likely to drop (51.3 M) in 2024.

OncoCyte Corp fundamental ratios Correlations

0.410.910.890.950.91-0.8-0.750.980.860.990.570.080.850.770.68-0.550.95-0.420.980.910.88-0.040.930.80.82
0.410.270.550.520.48-0.06-0.250.270.270.430.510.640.260.280.22-0.240.360.020.320.480.270.580.280.30.41
0.910.270.890.840.92-0.77-0.770.910.80.90.39-0.160.770.770.69-0.670.94-0.480.910.920.82-0.20.870.80.78
0.890.550.890.80.86-0.57-0.670.850.670.910.470.110.660.670.57-0.440.92-0.420.910.860.710.270.840.70.73
0.950.520.840.80.88-0.82-0.680.910.90.930.590.230.890.710.63-0.590.89-0.280.880.880.91-0.10.840.740.79
0.910.480.920.860.88-0.67-0.810.880.750.910.620.00.720.810.73-0.640.9-0.570.881.00.78-0.090.830.840.86
-0.8-0.06-0.77-0.57-0.82-0.670.54-0.85-0.98-0.72-0.240.09-0.97-0.56-0.50.62-0.780.2-0.74-0.67-0.960.44-0.74-0.6-0.56
-0.75-0.25-0.77-0.67-0.68-0.810.54-0.76-0.6-0.77-0.520.35-0.53-1.0-0.990.76-0.660.83-0.76-0.81-0.580.26-0.88-0.99-0.97
0.980.270.910.850.910.88-0.85-0.760.880.960.48-0.060.870.780.69-0.560.94-0.480.980.880.9-0.140.930.80.8
0.860.270.80.670.90.75-0.98-0.60.880.790.350.040.990.630.55-0.660.83-0.210.790.750.99-0.30.780.660.65
0.990.430.90.910.930.91-0.72-0.770.960.790.590.080.780.780.7-0.520.94-0.460.980.910.820.020.930.810.84
0.570.510.390.470.590.62-0.24-0.520.480.350.590.480.370.540.47-0.130.47-0.360.520.620.40.110.530.540.61
0.080.64-0.160.110.230.00.090.35-0.060.040.080.480.11-0.3-0.380.380.050.56-0.010.00.080.56-0.13-0.28-0.16
0.850.260.770.660.890.72-0.97-0.530.870.990.780.370.110.570.48-0.550.84-0.170.780.720.99-0.250.770.60.59
0.770.280.770.670.710.81-0.56-1.00.780.630.780.54-0.30.570.99-0.760.67-0.80.770.810.61-0.250.91.00.98
0.680.220.690.570.630.73-0.5-0.990.690.550.70.47-0.380.480.99-0.770.57-0.820.680.730.52-0.30.840.980.96
-0.55-0.24-0.67-0.44-0.59-0.640.620.76-0.56-0.66-0.52-0.130.38-0.55-0.76-0.77-0.470.45-0.5-0.64-0.560.47-0.61-0.77-0.72
0.950.360.940.920.890.9-0.78-0.660.940.830.940.470.050.840.670.57-0.47-0.390.950.90.88-0.010.870.710.72
-0.420.02-0.48-0.42-0.28-0.570.20.83-0.48-0.21-0.46-0.360.56-0.17-0.8-0.820.45-0.39-0.5-0.57-0.240.18-0.61-0.79-0.74
0.980.320.910.910.880.88-0.74-0.760.980.790.980.52-0.010.780.770.68-0.50.95-0.50.880.820.00.940.790.8
0.910.480.920.860.881.0-0.67-0.810.880.750.910.620.00.720.810.73-0.640.9-0.570.880.78-0.090.830.840.86
0.880.270.820.710.910.78-0.96-0.580.90.990.820.40.080.990.610.52-0.560.88-0.240.820.78-0.240.80.650.64
-0.040.58-0.20.27-0.1-0.090.440.26-0.14-0.30.020.110.56-0.25-0.25-0.30.47-0.010.180.0-0.09-0.24-0.1-0.24-0.16
0.930.280.870.840.840.83-0.74-0.880.930.780.930.53-0.130.770.90.84-0.610.87-0.610.940.830.8-0.10.910.9
0.80.30.80.70.740.84-0.6-0.990.80.660.810.54-0.280.61.00.98-0.770.71-0.790.790.840.65-0.240.910.99
0.820.410.780.730.790.86-0.56-0.970.80.650.840.61-0.160.590.980.96-0.720.72-0.740.80.860.64-0.160.90.99
Click cells to compare fundamentals

OncoCyte Corp Account Relationship Matchups

OncoCyte Corp fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets39.9M55.4M159.6M100.1M74.9M49.1M
Short Long Term Debt Total5.9M8.6M5.7M3.5M2.9M4.1M
Other Current Liab2.6M5.3M9.4M9.2M4.9M4.7M
Total Current Liabilities4.4M9.0M14.1M12.1M7.2M7.6M
Total Stockholder Equity30.8M33.5M65.2M34.3M25.6M22.0M
Property Plant And Equipment Net3.7M6.5M8.5M10.9M5.4M3.8M
Net Debt(16.1M)1.5M(29.9M)(16.4M)(6.6M)(6.9M)
Retained Earnings(93.7M)(123.7M)(187.8M)(260.7M)(289.9M)(275.4M)
Accounts Payable469K432K1.8M1.3M953K621.2K
Cash22.1M7.1M35.6M20.0M9.4M12.8M
Non Current Assets Total16.9M46.2M120.4M74.6M64.2M33.5M
Non Currrent Assets Other2.2M1.9M2.0M2.1M2.2M1.5M
Other Assets2.2M2.1M2.0M1.01.151.09
Cash And Short Term Investments22.5M7.8M36.5M20.4M9.4M14.5M
Common Stock Total Equity124.6M157.2M253.0M294.9M339.2M356.1M
Common Stock Shares Outstanding2.6M3.3M4.4M5.5M7.7M8.0M
Short Term Investments428K379K675K904K433K0.0
Liabilities And Stockholders Equity39.9M55.4M159.6M100.1M74.9M49.1M
Other Current Assets505K1.2M3.9M3.1M782K1.1M
Other Stockholder Equity948K343K37K(5.3M)(4.8M)(4.5M)
Total Liab9.0M21.9M94.3M65.8M49.3M27.1M
Property Plant And Equipment Gross3.7M6.5M8.5M10.9M5.4M3.8M
Total Current Assets23.0M9.2M39.1M25.5M10.7M15.7M
Accumulated Other Comprehensive Income(343K)0.037K39K49K51.5K
Short Term Debt1.4M3.2M3.0M1.6M1.3M1.7M
Common Stock124.6M157.2M253.0M294.9M310.3M325.8M
Property Plant Equipment614K3.7M6.5M8.5M9.8M10.3M
Net Tangible Assets30.8M9.3M(44.7M)(22.0M)(19.8M)(18.8M)
Long Term Debt1.1M347K1.9M1.5M1.7M905.1K
Retained Earnings Total Equity(93.7M)(123.7M)(187.8M)(260.7M)(234.6M)(222.9M)
Long Term Debt Total1.4M534K2.0M1.5M1.7M1.2M
Non Current Liabilities Total4.6M12.9M80.2M53.7M42.1M26.9M
Capital Lease Obligations2.9M4.7M4.4M3.5M2.9M2.8M
Net Invested Capital33.9M37.4M66.5M34.3M20.5M32.0M
Net Working Capital18.5M230K25.0M13.4M3.5M3.3M
Capital Stock124.6M157.2M253.0M294.9M310.3M222.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for OncoCyte Stock Analysis

When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.